[DOI] [PubMed] [Google Scholar] 248.Liu Y., Cotillard A., Vatier C., Bastard J.-P., Fellahi S., Stvant M., Allatif O., Langlois C., Bieuvelet S., Brochot A., et al
Here's what Anthem members should know: TrumpRx Program Now Live The Trump administration launched TrumpRx.gov on February 6, 2026, offering GLP-1s at discounted prices: [15] Current pricing: ~$346/month for Zepbound (via Eli Lilly partnership) Price trajectory: Expected to drop to ~$245/month over 2 years Medicare/Medicaid: $245/month with $50 max copay (mid-2026+) How to access: Visit TrumpRx.gov This provides an alternative for Anthem members denied coverage
Further reading on GLP-1s and cancer risk: Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes (JAMA) GLP-1 Receptor Agonists and Cancer Risk in Adults With Obesity (JAMA) General Disclaimer This document is not intended to address any specific situation or to provide legal, regulatory, financial, or other advice
WeightWatchers, a stalwart in the field of weight management, is set to revolutionize the way we approach obesity with its groundbreaking GLP-1 program